FRASCOTTI GIANNI

Barbieri, L., Salvioni, L., Banfi, A., Garbujo, S., Fiandra, L., Baioni, C., et al. (2025). Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer. ACS APPLIED MATERIALS & INTERFACES [10.1021/acsami.5c06626]. Detail

Tomaino, G., Pantaleoni, C., D'Urzo, A., Santambrogio, C., Testa, F., Ciprandi, M., et al. (2024). An Efficient Method for Vault Nanoparticle Conjugation with Finely Adjustable Amounts of Antibodies and Small Molecules. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25(12) [10.3390/ijms25126629]. Detail

Tomaino, G., Pantaleoni, C., Ami, D., Pellecchia, F., Dutriaux, A., Barbieri, L., et al. (2023). Addressing Critical Issues Related to Storage and Stability of the Vault Nanoparticle Expressed and Purified from Komagataella phaffi. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(4) [10.3390/ijms24044214]. Detail

Frascotti, G., Galbiati, E., Mazzucchelli, M., Pozzi, M., Salvioni, L., Vertemara, J., et al. (2021). The vault nanoparticle: A gigantic ribonucleoprotein assembly involved in diverse physiological and pathological phenomena and an ideal nanovector for drug delivery and therapy. CANCERS, 13(4), 1-37 [10.3390/cancers13040707]. Detail

Garbujo, S., Galbiati, E., Salvioni, L., Mazzucchelli, M., Frascotti, G., Sun, X., et al. (2020). Functionalization of colloidal nanoparticles with a discrete number of ligands based on a “HALO-bioclick” reaction. CHEMICAL COMMUNICATIONS, 56(77), 11398-11401 [10.1039/d0cc04355a]. Detail